Greenleaf Trust’s Globus Medical GMED Stock Holding History

Greenleaf Trust’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$332K	Buy	3,857 +27	+0.7%	+$2.42K	﹤0.01%	617
2025 Q4	$334K	Buy	3,830 +11	+0.3%	+$835	﹤0.01%	613
2025 Q3	$219K	Sell	3,819 -622	-14%	-$35.8K	﹤0.01%	755
2025 Q2	$262K	Sell	4,441 -151	-3%	-$9.76K	﹤0.01%	678
2025 Q1	$336K	Sell	4,592 -6	-0.1%	-$496	﹤0.01%	608
2024 Q4	$380K	Sell	4,598 -48	-1%	-$3.79K	﹤0.01%	579
2024 Q3	$332K	Buy	4,646 +61	+1%	+$4.31K	﹤0.01%	630
2024 Q2	$314K	Buy	4,585 +23	+0.5%	+$1.37K	﹤0.01%	608
2024 Q1	$245K	Sell	4,562 -91	-2%	-$4.89K	﹤0.01%	677
2023 Q4	$248K	Buy	+4,653	New	+$227K	﹤0.01%	649

Other funds holding GMED

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Bank of Montreal

Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return